125.90
Glaukos Corporation (GKOS) 最新ニュース
Why (GKOS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Why Analysts See The Glaukos (GKOS) Story Shifting After The Latest Price Target Change - Yahoo Finance
GKOS: Stifel Boosts Glaukos Price Target to $160 with Buy Rating | GKOS Stock News - GuruFocus
Stifel Nicolaus Issues Positive Forecast for Glaukos (NYSE:GKOS) Stock Price - MarketBeat
Glaukos stock price target raised to $160 from $115 at Stifel on Epioxa outlook - Investing.com
What makes Glaukos (GKOS) a good investment? - MSN
What Makes Glaukos (GKOS) a Good Investment? - Insider Monkey
Glaukos Advances Phase 3 Glaucoma Implant Trial, Keeping GKOS in Focus for Investors - TipRanks
Tuesday Insider Activity: Top Execs Make Moves at Reddit, Glaukos By Investing.com - Investing.com Nigeria
Tuesday Insider Activity: Top Execs Make Moves at Reddit, Glaukos - Investing.com
Aug Macro: Is Glaukos Corporation affected by consumer sentimentTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Glaukos (NYSE:GKOS) CEO Sells $10,126,325.00 in Stock - MarketBeat
Glaukos (NYSE:GKOS) CEO Thomas William Burns Sells 186,945 Shares - MarketBeat
Burns, Glaukos chairman & ceo, sells $31.6 million in GKOS stock - Investing.com UK
Burns, Glaukos chairman & ceo, sells $31.6 million in GKOS stock By Investing.com - Investing.com South Africa
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 - Business Wire
How Glaukos Corporation stock performs in rate cut cyclesMarket Risk Summary & Low Volatility Stock Suggestions - bollywoodhelpline.com
EPS Watch: What hedge funds are buying ProShares Trust ProShares UltraShort FTSE China 50Share Buyback & Trade Opportunity Analysis - baoquankhu1.vn
Glaukos Sees Revenue Surge as Analysts Raise Price Targets - StocksToTrade
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Glaukos (GKOS) - The Globe and Mail
How Glaukos’ Reaffirmed 2026 Sales Guidance and iDose TR Momentum Will Impact Glaukos (GKOS) Investors - simplywall.st
Glaukos (NYSE:GKOS) Trading 7.8% HigherHere's What Happened - MarketBeat
Glaukos Surges with Strong Year-End Financials and Optimistic Future Outlook - StocksToTrade
Glaukos Reports Preliminary Q4 and 2025 Results, Reaffirms 2026 Revenue Guidance - VisionMonday.com
Needham Reiterates Buy Rating for Glaukos (GKOS) | GKOS Stock Ne - GuruFocus
Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy By Investing.com - Investing.com Australia
Glaukos (NYSE:GKOS) Shares Gap DownHere's What Happened - MarketBeat
Glaukos stock falls despite strong Q4 revenue beat, UBS reiterates Buy - Investing.com Canada
Glaukos (GKOS) Shares Drop Significantly in Recent Trading - GuruFocus
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1% - Intellectia AI
Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results - Investing.com Australia
Glaukos' (GKOS) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Glaukos stock holds Overweight rating at Piper Sandler on strong Q4 results By Investing.com - Investing.com Nigeria
Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
S&P 500 Futures Fall in Premarket Trading; Glaukos, Fortinet Lag - Barron's
What 14 Analyst Ratings Have To Say About Glaukos - Benzinga
Breakout Move: What is the long term forecast for Glaukos Corporation stockPortfolio Performance Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Glaukos reports 36% revenue growth in Q4, reaffirms 2026 guidance By Investing.com - Investing.com Nigeria
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2 - PharmiWeb.com
Glimpse Into Glaukos (GKOS): Financial Standing and Cash Reserves - GuruFocus
Glaukos Reports Strong Preliminary Q4 and 2025 Sales Growth - TipRanks
Glaukos (GKOS) Reaffirms 2026 Revenue Forecast at $600M-$620M - GuruFocus
Glaukos (GKOS) Projects Strong Q4 Glaucoma Sales Performance - GuruFocus
Glaukos stock falls after preliminary Q4 sales beat estimates By Investing.com - Investing.com Nigeria
Glaukos reports 36% revenue growth in Q4, reaffirms 2026 guidance - Investing.com
Glaukos Reaffirms 2026 Revenue Guidance of $600 Million to $620 Million, Shares Fall After Hours - marketscreener.com
Glaukos stock falls after preliminary Q4 sales beat estimates - Investing.com UK
Glaukos announces preliminary, unaudited fourth quarter results - marketscreener.com
大文字化:
|
ボリューム (24 時間):